Med Holdings Group Inc. has entered advanced negotiations with nationally recognized urology and sexual wellness specialist Dr. Harvey Samowitz, a move that would significantly strengthen the company's clinical leadership during a period of rapid expansion. Dr. Samowitz brings more than 30 years of experience in urology, sexual medicine, and pelvic health, with board certification from the American Board of Urology and subspecialty certification in Female Pelvic Medicine and Reconstructive Surgery.
The potential addition of Dr. Samowitz represents a strategic alignment with elite medical leadership as Med Holdings Group positions itself for sustained growth. Chief Executive Officer Jessica Miller stated the company's strategy focuses on aligning with top professionals while scaling into high-demand markets and accelerating compliance milestones. Dr. Samowitz maintains affiliations with several prominent medical organizations including the American Urological Association, American College of Surgeons, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction.
Concurrently with these negotiations, Med Holdings Group is actively expanding into high-growth markets with negotiations for two additional locations in Jupiter, Florida and Doral, Florida. These markets align with the company's demographic strategy targeting high-income populations, with management anticipating these additions will strengthen recurring revenue and regional brand dominance. The company is also accelerating completion of its audit process while advancing its FINRA name change and ticker symbol change to enhance transparency and market visibility.
A significant development in the company's expansion strategy is the official launch of its enhanced national platform at https://www.totallbody.com, which significantly expands the company's addressable market beyond physical locations. The digital platform provides immediate national brand exposure and access to a large, underserved U.S. market while offering scalable digital engagement for services and future vertical expansion. Management views this as a foundational step toward building a nationally scalable healthcare platform.
Market momentum appears to support the company's strategic direction, with the company's stock appreciating more than 500% over the past twelve months and market capitalization now exceeding $3 million. Management believes this growth reflects increasing investor awareness of the company's strategic execution. With committed expansion capital, a clear acquisition and multi-location rollout strategy, accelerating compliance milestones, expanding clinical leadership, and a scalable national digital infrastructure, Med Holdings Group believes it is strategically positioned for continued operational and market growth into 2026 and beyond.
The company's approach combines physical expansion with digital scale, creating a hybrid healthcare delivery model that could reshape how specialty medical services reach patients. By targeting both high-income demographic markets through physical locations and broader national audiences through its digital platform, Med Holdings Group is attempting to capture multiple segments of the growing wellness and specialty medical markets. The potential addition of Dr. Samowitz would provide clinical credibility to these expansion efforts while the company's compliance milestones aim to strengthen its corporate standing in the healthcare sector.
